首页> 外文期刊>Molecular Genetics & Genomic Medicine >Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
【24h】

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype

机译:染色体微阵列分析在胎儿血清半透明和正常核型中的临床应用

获取原文
           

摘要

Background Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT?≥?3.5?mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value of NT for karyotype analysis (NT of 2.5?mm in China) and the recommended cutoff value for CMA (NT of 3.5?mm) whether should be excluded from CMA test. Methods Singleton pregnant women ( N ?=?192) who had undergone invasive procedures owing to an increased NT (NT?≥?2.5?mm) were enrolled. Fetal cells were collected and subjected to single nucleotide polymorphism array and karyotype analyses simultaneously. Cases were excluded if the karyotype analysis indicated aneuploidy and apparent structural aberrations. Results Fourteen cases of aneuploidy and four cases of structural abnormalities were excluded. Of the remaining 174 cases, 119 fetuses had NTs of 2.5–3.4?mm, and 55 fetuses with NT?≥?3.5?mm. Eleven copy number variants (CNVs) were identified. In fetuses with smaller NTs, six (6/119, 5.9%) variations were detected, including two (2/119, 1.6%) clinically significant CNVs (pathogenic or likely pathogenic CNV), one? likely benign CNV, two variants unknown significance, and one incidental CNV. Five (5/55, 9.1%) variations were found in fetuses with NT?≥?3.5?mm. Among these CNVs, three (3/55, 5.5%) cases had clinically significant CNVs, and two had likely benign CNV. There were no statistically significant differences?in?the incidence of all CNVs and clinically significant CNVs in the two?groups ( p ??0.05). Conclusion CMA improved the diagnostic yield of chromosomal aberrations for fetuses with NTs of 2.5–3.4?mm?and apparently normal karyotype, regardless of whether other ultrasonic abnormalities were observed.
机译:背景技术亚型染色体不平衡与颈部半透明(NT)增加有关。最先前的研究推荐使用染色体微阵列分析(CMA)进行产前诊断,如果NT?≥≤3.5?mm。但是,对CMA的截止值没有目前的全球共识。在这项研究中,我们旨在讨论NT较小的胎儿,其在NT的核型分析(NT在中国的NT为2.5Ωmm)之间的截止值之间,以及CMA的推荐截止值(NT为3.5Ωmm)是否应该是从CMA测试中排除。方法注册了因NT(NTα≥≤2.5mm)而受到侵入性手术的单身孕妇(n?='192)。收集胎儿细胞并同时进行单核苷酸多态性阵列和核型分析。如果核型分析表明非倍差和表观结构像差,则排除了病例。结果排除了四件儿交通倍性和四例结构异常情况。其余174例,119个胎儿的NTS为2.5-3.4Ωmm,55个胎儿,NT?≥≤3.5?mm。确定了十一拷贝数变体(CNV)。在具有较小NTS的胎儿中,检测到六(6/119,5.9%)变化,包括临床上显着的CNV(致病或可能的病原CNV)两(2/119,1.6%)?可能良性CNV,两种变体不明意义,以及一个偶然的CNV。在胎儿中发现五(5/55,9.1%)变化,NT≥≤3.5?mm。在这些CNV中,三种(3/55,5.5%)病例有临床显着的CNV,两种可能有可能良性CNV。没有统计学上显着的差异?在?所有CNVs的发病率和两种临床上有显着的CNVs(P?>?0.05)。结论CMA改善了NTS的胎儿染色体畸变的诊断产率为2.5-3.4ΩΩmm?和明显正常的核型,无论是否观察到其他超声异常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号